Development of stability indicating, validated single dissolution method for simultaneous estimation of clopidogrel bisulfate and rivaroxaban in tablet dosage formulation by RP-HPLC method

• Päätekijät: Rupali Sajjanwar (Tekijä), Shyamala Bhaskaran (Tekijä), Kulesh Kakati (Tekijä), Shailendra Kumar Jha (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Creative Pharma Assent, 2015-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

A dissolution method was developed for combination of two drugs which are already marketed as an individual product, Clopidogrel Bisulfate Tablets USP 75 mg and another is Rivaroxaban Tablets 10 mg & 20 mg. It was emphasized that both products have several advantages when given as combination th...